Health DiagnosticsNutraceuticalLifestyleBiotechnologyManufacturingProduct ResearchWellness
Description
Niagen Bioscience, Inc. operates as a global bioscience company. The company is dedicated to healthy aging.
Consumer Products segment
This segment provides finished dietary supplement products that contain the company's proprietary ingredients, com…
Analysis
Middle-of-the-road
Niagen Bioscience, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is attractive. The owner-earnings multiple stands at 14.2×; owner earnings: the cash an owner could take out each year.
Growth is moderate; the safety picture is sturdy. The company scores 14/20 on our value-creation score: strong value creator.
Flags to be aware of: Some accounting patterns deserve a closer look. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202316
71
2023202420252026
All-time high
71
Mar 2026
All-time low
14
Jan 2024
Average rank
43
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
76
45
80
77
Price/Earnings
42
11
32
44
Price/Book
48
5
32
26
Dividend Yield
1
1
1
1
Value (overall)
51
10
45
45
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.